PD-0138: Real-time EPID based delivery verification during lung stereotactic body radiotherapy: initial experience  by Greer, P.B. et al.
3rd ESTRO Forum 2015                                                                                                                                         S65 
 
 
Poster Discussion: Imaging  
 
 
PD-0137   
Ultrasound Computed tomography for early breast cancer 
detection 
M. Perez-Liva1, J.L. Herraiz2, L. Medina-Valdés3, J. Camacho3, 
C. Fritsch3, P. Ibáñez1, J.M. Udías1 
1Universidad Complutense de Madrid (UCM), Departamento 
de Física Atómica Molecular y Nuclear, Madrid, Spain  
2Massachusetts Institute of Technology (MIT), Madrid-MIT 
M+VISION Consortium, Boston, USA  
3Consejo Superior de Investigaciones Científicas (CSIC), 
Instituto de Tecnologías Físicas y de la Información, Madrid, 
Spain  
 
Purpose/Objective: This work presents preliminary results of 
image reconstruction methods for an Ultrasound Computed 
Tomography System (UCTS) for early detection of breast 
cancer. This system aims to avoid common downsides present 
in conventional mammography, such as radiation risk, 
moderate sensitivity in dense breast tissue (particularly 
prone to develop cancer) and incorrect lesion location after 
breast decompressing. The potential of these systems as a 
main diagnostic or screening tool is currently limited by the 
computational cost of data processing and image 
reconstruction. Therefore, we are investigating new methods 
for speeding-up image formation without significantly 
compromising the image quality. 
Materials and Methods: We have implemented two common 
iterative reconstruction algorithms, ML-EM (1) and SART (2). 
The code was developed in Matlab® and employs non-linear 
ray theory by means of the Fast Marching Method (3) for the 
forward and backward propagation.  
The method was tested with both simulated and 
experimental data. The simulated data was obtained with a 
full wave code (4) and a numerical breast phantom. For the 
experiments, we used our first prototype of UCTS (a pair of 
independent 128-element, 3.2 MHz array transducers 
mechanically moved describing a circle of 100 mm radius). An 
agar-glycerin-gelatin phantom was employed for these tests. 
In both simulations and experiment, 200 emitter-receiver 
pairs were used and the images were reconstructed in 2D 
mode with 1 mm pixel. 
We evaluated four quality parameters in the reconstructed 
images: detectability, uniformity, resolution and contrast. 
Results: Concerning detectability we were able to detect 
masses down to 1 mm radius for both ML-EM and SART 
algorithms. ML-EM reaches better detectability in shorter 
times. Uniformity is referred to the noise in the different 
lesions and in all the cases was less than 15%. The resolution 
was estimated to be ~ 2 mm based on the capability to 
discern masses separated up to 2 pixels. Finally, the contrast 
was evaluated as the ratio of the sound speed in different 
tissues respect to the water background, obtaining the 
expected unbiased results. The approximate time of 
convergence per slice is ~10 minutes for ML-EM and SART, 
although we expect to reduce it by the parallelization of the 
code.  
Conclusions: A code based on non-linear ray theory was 
developed for UCTS in transmission mode. The obtained 
images with both simulated and experimental data present 
correct quality parameters and can be obtained in a 
reasonable amount of time, which will facilitate its use in the 
future and will expand the possibilities and applications of 
this new technique. 
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Purpose/Objective: The increased use of advanced delivery 
techniques with a reduced number of treatment fractions 
places an emphasis on the need to perform patient based 
quality assurance that is both efficient and able to identify 
delivery errors at the time of delivery.  
Materials and Methods: A novel in-house designed real-time 
verification system (WatchDog) uses a stream of EPID 
acquired images during treatment and compares them 
against a reference dataset of predicted images [1]. A 
comparison is performed in near real time (0.1 sec) and 
produces a χ pass-rate for each frame based on chosen 
criteria.  
In this study WatchDog is used to monitor a right sided lung 
SBRT treatment. The lesion demonstrated  
To assess the effect of patient positioning error, an 
additional evaluation is performed with the planning CT 
offset by 4 mm in the superior direction.  
Results are reported in two ways: 1) a χ value based on 
integrating the frames over the whole treatment (integrated 
χ) and 2) a χ value based on summing frames up to each point 
in the delivery (cumulative χ) 
Results: With a 4%/4mm criteria, the integrated χ pass-rates 
for each of the eight measured treatment arcs range from 
96.9 – 99.9%. The corresponding mean cumulative χ pass-
rates range from 91.5 – 99.0%. With a 2%/2 mm criteria the 
corresponding pass-rates range from 93.7 – 99.0% and 87.3—
94.9% respectively. The figure shows the cumulative (from 
right to left) χ vs gantry angle for an actual treatment 
delivery (red) and with the introduced 4 mm shift (blue).  
With the 4 mm offset introduced, the 4%/4 mm integrated 
and mean cumulative χ pass-rates remain similar at 97.8—
99.6% and 92.9—97.9% respectively. The 2%/2 mm integrated 
values fall to 90.1—95.1%, but a much greater drop is 
observed when analysing mean cumulative χ pass-rates with 
these parameters, which lie between 80.1—89.2%.  
 
Conclusions: We have demonstrated the feasibility of using 
WatchDog to monitor lung SBRT treatments in real-time for 
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the verification of treatment delivery. Using the real-time 
cumulative χ we are able to demonstrate an improved ability 
to identify small but potentially significant positional errors 
when compared to using only the integrated image χ value.  
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Purpose/Objective: Proton computed tomography (CT) has 
been described as a solution to image the proton relative 
stopping power (RSP) of patient tissues and could therefore 
reduce the uncertainty and associated margins of the 
conversion of X-ray CT images to RSP maps. Several studies 
have already demonstrated the capability of proton imaging 
to reconstruct tissue RSP but the quantification of the 
improvement with respect to X-ray CT is still missing. This 
study aimed at quantifying the accuracy of RSP maps 
reconstructed from X-ray and proton CT and their impact on 
the prediction of proton ranges under idealized conditions, 
i.e., perfect detectors for the position and the energy of 
protons and realistic but perfectly known X-ray source and 
flat panel. 
Materials and Methods: We have developed a Monte Carlo 
framework to assess proton CT performances for the main 
steps of a proton therapy treatment planning, i.e., proton or 
X-ray CT acquisition and reconstruction, conversion to RSP 
maps based on the calibration of a tissue phantom, and 
proton dose simulations. The RSP maps obtained from X-ray 
CT images rely on the calibration curve that converts 
Hounsfield units into RSP. Two different approaches (linear 
interpolation and least-squares minimization) were tested to 
determine the impact of this calibration. In-silico pencil 
beams were simulated to a computational phantom on 
various anatomical sites and the proton range was assessed 
on the reference, the proton CT-based and the X-ray CT-
based material maps. 
Results: The imaging dose delivered by a proton CT scanner 
appeared impressively uniform and conformal to the imaging 
beam. Comparison of the RSP maps showed that proton CT 
enables a more precise RSP reconstruction of all anatomical 
sites (Figure 1). The spatial distribution of the RSP deviation 
also shows that the accuracy of proton CT reconstruction is 
more uniform. This weaker tissue dependence could help to 
produce a more robust estimate of the proton range between 
patients. As expected from the RSP reconstruction, proton CT 
gave a more precise estimate of the proton range with a 
mean range deviation of only 0.3%, which was at least 60% 
smaller than the X-ray CT predictions. 
 
Figure 1. Absolute deviation of the RSP for liver, head and 
lungs sites for proton CT (left) and for X-ray CT using a 
linearly interpolated calibration (middle) or a least-squares 
fit (right). 
Conclusions: A Monte Carlo framework has been developed 
to assess the performances of proton CT for the simulation of 
the patient dose in proton therapy. Considering ideal 
detectors performances, the reconstructed RSP maps with 
proton CT were more accurate than the RSP maps obtained 
from X-ray CT images. Proton range calculations based on 
proton CT are therefore both more precise and more uniform 
with a weaker dependence to the spatial distribution of 
tissues. Smaller treatment margins could therefore be used if 
proton CT was available to plan proton therapy. Proton CT 
also benefits from the uniformity of the imaging dose 
distribution and its high conformation to the primary beam 
region.  
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Purpose/Objective: Particle induced x-ray emission (PIXE), 
commonly based on detection of characteristic x-rays upon 
irradiation with a low-energy proton beam, is a useful tool 
for high-sensitivity material analysis of thin samples. We 
propose to investigate the feasibility of proton induced x-ray 
fluorescence (pXRF) for range verification in proton therapy. 
The goal of this work was to demonstrate the feasibility of 
proton-induced x-ray fluorescence CT (pXFCT) imaging of 
gold placed in a phantom by means of experiments and Monte 
Carlo (MC) simulations. 
Materials and Methods: First, proton induced gold x-ray 
fluorescence (pXRF) was measured as a function of gold 
concentration. Vials of 2.2 cm in diameter filled with 0-5% Au 
solutions were irradiated with a 3×1011 220 MeV protons of 7-
mm FWHM. X-ray fluorescence induced by the interaction of 
protons and Au was detected with a 3×3 mm2 CdTe detector 
placed at 90° with respect to the incident proton beam at a 
distance of 45 cm from the vials. Second, a 7-cm diameter 
water phantom containing three 2.2-diameter vials with 3%, 
4%, and 5% Au solutions was imaged with the 7-mm 220 MeV 
proton beam in a 1st generation CT scanning geometry 
(Figure 1a). 21 translational steps spaced by 3 mm at each of 
